ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,190Medicare Part D Prescriptions Filled, Including Refills

Rank: 205 out of 783

$474K Total Retail Price of All Prescriptions

Rank: 288 out of 783

363 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 363 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

38% of this provider’s 363 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 5,465 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 976 350 S3 1 2
AMLODIPINE BESYLATE 327 235 2 5
SIMVASTATIN 300 244 3 3
LISINOPRIL 235 180 4 4
FUROSEMIDE 210 125 5 7
OXYCODONE-ACETAMINOPHEN 163 46 S2 6 76
TRIAMTERENE-HCTZ 137 74 7 42
ZOLPIDEM TARTRATE 126 60 8 23
OXYCODONE HCL 124 14 S2 9 123
METOPROLOL TARTRATE 122 63 10 9
POTASSIUM CHLORIDE 121 89 11 16
NEXIUM 120 40 12 28
HYDROCHLOROTHIAZIDE 116 106 13 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 115 81 14 33
LEVOTHYROXINE SODIUM 112 61 15 1
OXYCODONE HCL-ACETAMINOPHEN 109 16 S2 16 86
TRAZODONE HCL 107 64 17 39
CARVEDILOL 98 40 18 21
CLONIDINE HCL 96 65 19 60
ATENOLOL 92 67 20 17
CYCLOBENZAPRINE HCL 92 0 R 20 63
GABAPENTIN 90 46 22 15
AMOXICILLIN 86 66 23 116
PROMETHAZINE HCL 85 28 R 24 97
METFORMIN HCL 82 58 25 8
ALLOPURINOL 80 68 26 31
OMEPRAZOLE 77 37 27 6
GLIMEPIRIDE 76 74 28 34
FENTANYL 75 11 S2 29 65
TRAMADOL HCL 74 45 30 20
CILOSTAZOL 73 45 31 232
ACETAMINOPHEN-CODEINE 71 62 S3 32 144
METOPROLOL SUCCINATE 71 52 32 13
PROAIR HFA 70 26 34 56
MORPHINE SULFATE ER 69 19 S2 35 107
WARFARIN SODIUM 69 39 35 10
NAPROXEN 67 39 37 104
TAMSULOSIN HCL 67 65 37 26
NIFEDIPINE ER 65 57 39 135
IBUPROFEN 64 13 40 115
ATORVASTATIN CALCIUM 64 57 40 11
KLOR-CON M20 62 59 42 48
INSULIN SYRINGE 58 41 43 82
PREDNISONE 56 38 44 36
DOXAZOSIN MESYLATE 56 54 44 87
CIPROFLOXACIN HCL 55 24 46 62
CITALOPRAM HBR 55 36 46 19
AMLODIPINE BESYLATE-BENAZEPRIL 54 43 48 83
DONEPEZIL HCL 53 50 49 24
DIOVAN 53 53 49 49
SERTRALINE HCL 53 37 49 22
CEPHALEXIN 52 31 52 70
GLIPIZIDE 52 43 52 71
HYDRALAZINE HCL 52 38 52 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.